Patient’s preferences for health scenarios associated with hepatitis C and its treatment

BACKGROUND AND AIM: Antiviral therapy with peg-interferon and ribavirin induces sustained virus eradication in 40%–80% of patients with chronic hepatitis C virus (HCV). We investigated patient views on their involvement in therapeutic decision making and on the desirability of disease and treatment-...

Descripción completa

Detalles Bibliográficos
Autor principal: Tinè, Fabio
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802077/
https://www.ncbi.nlm.nih.gov/pubmed/20054442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802077/
https://www.ncbi.nlm.nih.gov/pubmed/20054442

Ejemplares similares